Evidence map›Paper›PMID 32950462›Full record

ArticleAmerican heart journal2020

Geographical affiliation with top 10 NIH-funded academic medical centers and differences between mortality from cardiovascular disease and cancer.

Suveen Angraal, César Caraballo, Peter Kahn, Ambika Bhatnagar, Bikramjot Singh, F Perry Wilson, Mona Fiuzat, Christopher M O'Connor, Larry A Allen, Nihar R Desai and 2 more

Open access · greenAbstract readLetter
In one paragraph

Article in American heart journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Suveen AngraalDepartment of Internal Medicine, University of Missouri Kansas City School of Medicine, Kansas City, MO.
César CaraballoCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT.
Peter KahnDivision of Internal Medicine, Yale School of Medicine, New Haven, CT.
Ambika BhatnagarDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN.
Bikramjot SinghEvalueserve, Raleigh, NC.
F Perry WilsonProgram for Applied and Translational Research, Yale School of Medicine, New Haven, CT.
Mona FiuzatDuke University and Duke Clinical Research Institute, Durham, NC.
Christopher M O'ConnorDivision of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO.
Larry A AllenSection of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT.
Nihar R DesaiCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT.
Ronac MamtaniDivision of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA.
Tariq AhmadCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT. Electronic address: tariq.ahmad@yale.edu.
Yale University · USDuke University · USHospital of the University of Pennsylvania · USIndiana University – Purdue University Indianapolis · USUniversity of Colorado Denver · USUniversity of Missouri–Kansas City · USYale New Haven Hospital · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Renal Physiology and Phenotyping CoreP30DK079310 · NIDDK · YALE UNIVERSITY · PI ARONSON, PETER S. · 2008 to 2022
$16.8M
Optimizing Electronic Alerts for Acute Kidney InjuryR01DK113191 · NIDDK · YALE UNIVERSITY · PI WILSON, FRANCIS PERRY · 2018 to 2022
$3.1M
NCATS NIH HHS UL1 TR001863NIDDK NIH HHS P30 DK079310NIDDK NIH HHS R01 DK113191
6 · The paper itself

Abstract

Community engagement and rapid translation of findings for the benefit of patients has been noted as a major criterion for NIH decisions regarding allocation of funds for research priorities. We aimed to examine whether the presence of top NIH-funded institutions resulted in a benefit on the cardiovascular and cancer mortality of their local population. METHODS AND

resultsBased on the annual NIH funding of every academic medical from 1995 through 2014, the top 10 funded institutes were identified and the counties where they were located constituted the index group. The comparison group was created by matching each index county to another county which lacks an NIH-funded institute based on sociodemographic characteristics. We compared temporal trends of age-standardized cardiovascular mortality between the index counties and matched counties and states. This analysis was repeated for cancer mortality as a sensitivity analysis. From 1980 through 2014, the annual cardiovascular mortality rates declined in all counties. In the index group, the average decline in cardiovascular mortality rate was 51.5 per 100,000 population (95% CI, 46.8-56.2), compared to 49.7 per 100,000 population (95% CI, 45.9-53.5) in the matched group (P = .27). Trends in cardiovascular mortality of the index counties were similar to the cardiovascular mortality trends of their respective states. Cancer mortality rates declined at higher rates in counties with top NIH-funded medical centers (P < .001).

conclusionsCardiovascular mortality rates have decreased with no apparent incremental benefit for communities with top NIH-funded institutions, underscoring the need for an increased focus on implementation science in cardiovascular diseases.

Indexed as

Financing, GovernmentNational Institutes of Health (U.S.)Academic Medical CentersAdultAge FactorsCardiovascular DiseasesConfidence IntervalsFemaleHumansMaleMortalityNeoplasmsRural Health ServicesUnited StatesUrban Health Services

Identifiers

PMID32950462
PMCPMC7734611
OpenAlexW3087474802

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.